多发性骨髓瘤的支持性治疗：现状与进展。
Supportive care in multiple myeloma: Current practices and advances.
机构信息
Division of Hematology, Mayo Clinic Rochester, United States.
Division of Hematology, Mayo Clinic Rochester, United States.
出版信息
Cancer Treat Res Commun. 2021;29:100476. doi: 10.1016/j.ctarc.2021.100476. Epub 2021 Oct 9.
Abstract
Supportive care in multiple myeloma (MM) can have a major impact on quality of life and the survival outcomes of MM patients. In this review, we will focus on disease and treatment related toxicities experienced by MM patients and what are the best approaches to date to help mitigate the effects. We will specifically focus on a practical approach to managing bone disease, thrombosis, infection risk, peripheral neuropathy, dermatologic complications, gastrointestinal and ocular toxicities, and fatigue in MM.
摘要
在多发性骨髓瘤（MM）中，支持性护理可以对患者的生活质量和生存结果产生重大影响。在这篇综述中，我们将重点关注 MM 患者经历的疾病和治疗相关毒性，以及迄今为止帮助减轻这些影响的最佳方法。我们将特别关注管理 MM 患者骨骼疾病、血栓形成、感染风险、周围神经病、皮肤并发症、胃肠道和眼部毒性以及疲劳的实用方法。
相似文献
1
Supportive care in multiple myeloma: Current practices and advances.
Cancer Treat Res Commun. 2021;29:100476. doi: 10.1016/j.ctarc.2021.100476. Epub 2021 Oct 9.
2
Advances in supportive care for multiple myeloma.
J Natl Compr Canc Netw. 2014 Apr;12(4):502-11. doi: 10.6004/jnccn.2014.0055.
3
Supportive Care in Multiple Myeloma.
Curr Hematol Malig Rep. 2020 Apr;15(2):56-61. doi: 10.1007/s11899-020-00570-9.
4
Supportive care in multiple myeloma.
Clin Lymphoma Myeloma. 2006 Jul;7(1):42-50. doi: 10.3816/CLM.2006.n.038.
5
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.
J Clin Oncol. 2014 Feb 20;32(6):587-600. doi: 10.1200/JCO.2013.48.7934. Epub 2014 Jan 13.
6
Guidelines for supportive care in multiple myeloma 2011.
Br J Haematol. 2011 Jul;154(1):76-103. doi: 10.1111/j.1365-2141.2011.08574.x. Epub 2011 Apr 22.
7
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium.
Clin Lymphoma Myeloma Leuk. 2022 Jan;22(1):e41-e56. doi: 10.1016/j.clml.2021.07.028. Epub 2021 Aug 1.
8
Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United States.
Cancer. 2019 Nov 15;125(22):4084-4095. doi: 10.1002/cncr.32428. Epub 2019 Aug 5.
9
Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: A prospective, multi-centre longitudinal study.
Palliat Med. 2019 May;33(5):541-551. doi: 10.1177/0269216319833588.
10
[Current approaches to supportive care in multiple myeloma].
Srp Arh Celok Lek. 2011 Dec;139 Suppl 2:123-8. doi: 10.2298/sarh11s2123g.
引用本文的文献
1
Thromboprophylaxis in multiple myeloma.
Res Pract Thromb Haemost. 2025 Jan 16;9(1):102685. doi: 10.1016/j.rpth.2025.102685. eCollection 2025 Jan.
2
Frontline management of multiple myeloma patients: optimizing treatment for patients in the Gulf region.
Clin Hematol Int. 2025 Feb 11;7(1):14-28. doi: 10.46989/001c.128113. eCollection 2025.
3
Recent advances in the treatment and prevention of peripheral neuropathy after multiple myeloma treatment.
Ibrain. 2023 Sep 6;9(4):421-430. doi: 10.1002/ibra.12132. eCollection 2023 Winter.
4
Pain Management in Multiple Myeloma Patients: A Literature Review.
Cureus. 2024 Mar 11;16(3):e55975. doi: 10.7759/cureus.55975. eCollection 2024 Mar.
5
Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma.
Front Oncol. 2024 Mar 22;14:1282300. doi: 10.3389/fonc.2024.1282300. eCollection 2024.
6
Evolving progress in the management of malignant plasma cell disorders.
Cancer Treat Res Commun. 2022;32:100612. doi: 10.1016/j.ctarc.2022.100612. Epub 2022 Jul 19.
本文引用的文献
1
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis.
Br J Haematol. 2022 Jan;196(1):105-109. doi: 10.1111/bjh.17772. Epub 2021 Aug 15.
2
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
Blood Cancer J. 2021 May 26;11(5):103. doi: 10.1038/s41408-021-00494-4.
3
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study.
Br J Haematol. 2021 Jun;193(6):1213-1219. doi: 10.1111/bjh.17505. Epub 2021 May 17.
4
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma.
Lancet Haematol. 2021 Jun;8(6):e389-e392. doi: 10.1016/S2352-3026(21)00110-1. Epub 2021 Apr 19.
5
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma.
Clin Lymphoma Myeloma Leuk. 2021 May;21(5):e470-e476. doi: 10.1016/j.clml.2020.12.026. Epub 2021 Feb 7.
6
Cancer Statistics, 2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
7
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Blood. 2020 Dec 24;136(26):3033-3040. doi: 10.1182/blood.2020008150.
8
Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing stem cell transplantation.
J Geriatr Oncol. 2021 May;12(4):521-530. doi: 10.1016/j.jgo.2020.11.003. Epub 2020 Nov 20.
9
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study.
Blood Cancer J. 2020 Oct 23;10(10):106. doi: 10.1038/s41408-020-00369-0.
10
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol. 2020 Oct;21(10):1317-1330. doi: 10.1016/S1470-2045(20)30452-6. Epub 2020 Aug 28.
Zotero 插件